INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
INmune Bio Inc (INMB) Q4 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
INmune Bio Inc. (INMB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
INmune Bio Inc. Announces 2025 Results and Provides Business Update